Last updated on April 2018

Efficacy of TR 987 Beta-1 3-1 6-D-glucan in the Treatment of Chronic Venous Insufficiency Ulcers


Brief description of study

The safety and efficacy of beta glucan products, and specifically TR 987, in the treatment of chronic venous insufficiency ulcers has been established. This study is designed to determine the most efficient method of treatment.

Detailed Study Description

This is a multi-center, randomized, double-blind, placebo-controlled study to evaluate the effectiveness of TR 987 gel. It is a two-arm, design: One group will receive twice-weekly applications of 0.1% TR 987 in a gel base plus SoC for the first 4 weeks. The other group will receive twice-weekly applications of placebo gel base plus SoC for the same period of time. After 4 weeks, both groups will receive once weekly applications of their assigned treatment for the remaining 8 weeks of the trial. The Standard of Care therapy in this study is multi-layer compression therapy.

Clinical Study Identifier: NCT03154619

Contact Investigators or Research Sites near you

Start Over

Sharon McConnell, MS

GF Professional Research
Miami Lakes, FL United States
  Connect »

Sharon McConnell, MS

Summit Health Hospital
Chambersburg, PA United States
  Connect »

Sharon McConnell, MS

The Foot and Ankle Wellness Center
Ford City, PA United States
  Connect »

Keyur Patel, MD

Armstrong County Memorial Hospital
Kittanning, PA United States
  Connect »

Bryan Doner, DO

SerenaGroup Research Institute
Pittsburgh, PA United States
  Connect »

Maria Kasper, DPM

Martin Foot and Ankle
York, PA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.